Filing Details
- Accession Number:
- 0001628280-24-050111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-05 17:04:21
- Reporting Period:
- 2024-11-01
- Accepted Time:
- 2024-12-05 17:04:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1490829 | James Jones | 1600 West End Avenue, Suite 1300 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-01 | 76 | $1.15 | 37,947 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-04 | 49 | $1.17 | 37,996 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-05 | 76 | $1.20 | 38,072 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-06 | 76 | $1.20 | 38,148 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-07 | 76 | $1.17 | 38,224 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-08 | 76 | $1.18 | 38,300 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-11 | 76 | $1.20 | 38,376 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-12 | 76 | $1.20 | 38,452 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-13 | 76 | $1.20 | 38,528 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-14 | 76 | $1.19 | 38,604 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-15 | 76 | $1.17 | 38,680 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-18 | 76 | $1.18 | 38,756 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-19 | 76 | $1.15 | 38,832 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-20 | 85 | $1.13 | 38,917 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-21 | 85 | $1.09 | 39,002 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-22 | 75 | $1.07 | 39,077 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-25 | 75 | $1.09 | 39,152 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-26 | 75 | $1.11 | 39,227 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-27 | 75 | $1.15 | 39,302 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-29 | 75 | $1.32 | 39,377 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.